Researchers at Rochester Institute of Technology have created a toilet seat that detects congestive heart failure.
Prior to the acquisition, Brainlab had been an investor and distribution partner for Medineering for nearly three years.
FDA said Johnson & Johnson's Mentor unit and Sientra have failed to comply with post-approval study requirements for their silicone gel-filled breast implants.
A study demonstrated that after two years the minimally invasive iFuse procedure was more effective than conservative management.
Data from the UK’s National Health Service EndoBarrier Service show a significant reduction in HbA1c, weight, liver fat, and cardiovascular disease risks as well as a reduction in the need for insulin in some patients.
Alcon paid $285 million to acquire PowerVision, a company developing fluid-based intraocular lens implants.
The Cupertino, CA-based company released preliminary data from the Apple Heart Study, which demonstrates the effectiveness of wearables to detect atrial fibrillation.
R-One is the first European robotic solution to obtain the CE mark in the field of interventional cardiology.
Harvard Researchers have shed light on the liver and kidneys after toxin exposure, using machine learning.
FDA is calling on the public, scientists, and industry to help enhance the agency's understanding of materials science and to advance the development of safer medical device materials.
The Abbott Park, IL-based company’s expanded indication would allow the MitraClip to address the secondary form of mitral regurgitation and would significantly increase the amount of people with MR able to be treated by the device.
The Kalamazoo, MI-based company is expected to pay $110 million up front, plus an additional $110 million in milestones to pick up OrthoSpace.
Watchman has been a significant driver for Boston Scientific and is expected to have strong growth this year as well.